ABL Bio Inc
KOSDAQ:298380
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
KR |
|
S
|
SBI Investment Korea Co Ltd
KOSDAQ:019550
|
KR |
|
Uniflex Technology Inc
TWSE:3321
|
TW |
|
Movie Games SA
F:2LH
|
PL |
|
Y
|
Yamaha Motor Co Ltd
XMUN:YMA
|
JP |
|
Lucid Group Inc
F:CH2
|
US |
|
Iress Ltd
F:BRF
|
AU |
|
C
|
Christian Dior SE
XMUN:DIO
|
FR |
|
N
|
Nusantara Inti Corpora Tbk PT
IDX:UNIT
|
ID |
|
H
|
Haier Smart Home Co Ltd
F:690D
|
CN |
|
Syensqo NV
F:2NF
|
BE |
|
Kamada Ltd
NASDAQ:KMDA
|
IL |
|
B
|
Bristol-Myers Squibb Co
XMUN:BRM
|
US |
|
M
|
MTR Corp Ltd
XMUN:MRI
|
HK |
|
American Water Works Company Inc
NYSE:AWK
|
US |
|
H
|
Hyulim ROBOT Co Ltd
KOSDAQ:090710
|
KR |
|
Zscaler Inc
F:0ZC
|
US |
|
Asia Energy Logistics Group Ltd
F:EJ1C
|
HK |
Intrinsic Value
Is ABL Bio Inc undervalued or overvalued?
See the intrinsic value estimate for ABL Bio Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ABL Bio Inc looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ABL Bio Inc’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What ABL Bio Does
ABL Bio is a South Korean biotechnology company that discovers and develops antibody-based medicines. Its main work is creating biologic drug candidates, especially bispecific antibodies and antibody platforms designed to improve how cancer and neurological drugs reach their targets. It does not sell everyday consumer products; it sells drug development programs and licensing rights around its science.
- Headquarters
- Korea KR
- Employees
- 102
- IPO date
- Dec 19, 2018
ABL Bio has a narrow economic moat
ABL Bio Inc has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
ABL Bio Inc
Earnings Waterfall
ABL Bio Inc
The intrinsic value for ABL Bio Inc (298380) under the Base Case is hidden KRW.
Compared with the current market price of 46 750 KRW, the stock appears hidden.